Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorAntigens, CD34MelphalanLeukapheresisBlood Component RemovalCombined Modality TherapyTransplantation ConditioningMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsLymphoma, Non-HodgkinBusulfanMyeloablative AgonistsHematopoietic Stem CellsThiotepaEtoposideTreatment OutcomeCytophagocytosisCarmustineAntineoplastic Agents, AlkylatingRemission InductionIfosfamideGraft SurvivalBone Marrow TransplantationSalvage TherapyVincristineCytarabineHematopoiesisTransplantation, HomologousHodgkin DiseaseRecurrenceNeoplasmsBlood Transfusion, AutologousAmyloidosisLeukocytes, MononuclearBlood Cell CountBone Marrow PurgingPlatelet CountStem CellsDisease-Free SurvivalLymphoma, T-CellDoxorubicinStem Cell TransplantationCarboplatinRetrospective StudiesSurvival RateTime FactorsDexamethasoneRecombinant ProteinsGraft vs Host DiseasePrednisoneInfectionBlood CellsT-LymphocytesAntineoplastic AgentsSurvival AnalysisWhole-Body IrradiationLeukemia, Myeloid, AcuteImmunophenotypingLymphocytesFeasibility StudiesFollow-Up StudiesProspective StudiesLymphomaCell SeparationBreast NeoplasmsFlow CytometryLymphocyte ActivationFeverFatal OutcomeImmunomagnetic SeparationCells, CulturedCord Blood Stem Cell TransplantationGranulocyte-Macrophage Colony-Stimulating FactorCytomegalovirus InfectionsNeuroblastomaTissue DonorsInterleukin-2Immunosuppressive AgentsTransplantation ChimeraLeukocyte CountBlood DonorsHistocompatibilityKiller Cells, NaturalBone MarrowCytotoxicity, ImmunologicPrognosisAntigens, CDT-Lymphocytes, CytotoxicLeukemiaHistocompatibility TestingPOEMS SyndromeVidarabineCell CountBone Marrow Cells